UnitedHealth Group Incorporated $UNH Shares Sold by Bond & Devick Financial Network Inc.

Bond & Devick Financial Network Inc. decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% in the 2nd quarter, Holdings Channel reports. The firm owned 7,889 shares of the healthcare conglomerate’s stock after selling 402 shares during the period. UnitedHealth Group accounts for about 0.8% of Bond & Devick Financial Network Inc.’s investment portfolio, making the stock its 22nd biggest holding. Bond & Devick Financial Network Inc.’s holdings in UnitedHealth Group were worth $2,461,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Financial Management Professionals Inc. grew its holdings in shares of UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after buying an additional 17 shares during the period. Global Wealth Strategies & Associates raised its stake in UnitedHealth Group by 28.6% in the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after buying an additional 20 shares during the period. Retirement Planning Group LLC grew its stake in UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after buying an additional 21 shares during the last quarter. Net Worth Advisory Group increased its holdings in shares of UnitedHealth Group by 0.6% during the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock worth $1,907,000 after purchasing an additional 21 shares during the period. Finally, Bensler LLC grew its stake in UnitedHealth Group by 0.3% during the first quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock worth $3,637,000 after buying an additional 22 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

NYSE UNH opened at $336.72 on Friday. The company’s 50 day simple moving average is $295.67 and its two-hundred day simple moving average is $364.42. The stock has a market capitalization of $304.96 billion, a PE ratio of 14.59, a P/E/G ratio of 2.20 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group’s payout ratio is 38.30%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Barclays raised their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Morgan Stanley increased their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Truist Financial increased their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Oppenheimer lowered their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Finally, Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.